TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT06841861: Spermatogonial Differentiation Via Testicular Organoid

Sponsor: CellARTs Inc. · Phase: PHASE1/PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 100 pts

Competing Trials Overlap

3 Active Trials

Excess Burn Exposure

$9,030,400

Rescue Site Savings

+$5,954,420

Unlock Full NCT06841861 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06841861 Rescue Dossier →